History of Discovery: Inflammation in Atherosclerosis
By Peter Libby. Arteriosclerosis, Thrombosis and Vascular Biology, 2012
8,757 citations recorded by the source corpus.
Experimental work has elucidated molecular and cellular pathways of inflammation that promote atherosclerosis. Unraveling the roles of cytokines as inflammatory messengers provided a mechanism whereby risk factors for atherosclerosis can alter arterial biology, and produce a systemic milieu that favors atherothrombotic events. The discovery of the immune basis of allograft arteriosclerosis demonstrated that inflammation per se can drive arterial hyperplasia, even in the absence of traditional risk factors. Inflammation regulates aspects of plaque biology that trigger the thrombotic complications of atherosclerosis. Translation of these discoveries to humans has enabled both novel mechanistic insights and practical clinical advances.
Subfields: Epidemiology, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/60dfc0f284c6e37572d07ce7ceff903835f0510b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Immunology
In Molecular Biology
Citations in the corpus
- Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013, background): “Additional studies also showed that zinc decreased LPS-, ROS-, or TNF-a-induced NF-kB activation in endothelial cells and cancer cells (46).”
- NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases (2015, background): “Immune cells (macrophages and T cells), foam cells, vascular endothelial cells, smooth muscle cells (SMCs), platelets, extracellular matrix and a lipid rich core with extensive necrosis and fibrosis of surrounding tissues constitute the basic elements of atherosclerotic plaques [136,137].”
- Pathophysiology of Type 2 Diabetes Mellitus (2020, background): “At early stages of atherosclerosis, circulating LDL binds to matrix proteoglycans where their oxidation is favored, giving rise to highly pro-inflammatory particles that stimulate the expression of several adhesion molecules by endothelial cells [242,248].”
- Aging, frailty and age-related diseases (2010, background): “T-cells which bear activation markers (Libby 2002).”
- Immunity and Inflammation in atherosclerosis (2019, background): “nificant stenosis that restricts blood flow and causes critical tissue hypoxia.(3) The most common complications, myocar-”
- Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives (2011, background): “The pathophysiological factors leading to endothelial dysfunction that are especially relevant to the development of vascular disease include the following (2, 43, 213, 330, 338, 492, 493): 1) Activation by cytokines; 2) Stimulation by free radicals/ROS or oxidative stresses and the advanced glycati”
- Stroke Risk Factors, Genetics, and Prevention (2017, background): “and other mechanisms, CRP, cytokines, and other inflammatory mediators may directly contribute to stroke risk.(156)”
- LOX-1, OxLDL, and Atherosclerosis (2013, background): “2 Atherosclerosis is a chronic inflammatory vascular disease, having as ultimate outcome the atheromatous plaque, a focal lesion located within the intima of large and medium sized arteries [1, 2].”